NONALCOHOLIC FATTY LIVER DISEASE: CLINICAL FEATURES,DIAGNOSIS AND OUTCOMES

Authors

  • L.I. Makhmudova Author

DOI:

https://doi.org/10.5281/zenodo.20511832

Keywords:

NAFLD, insulin resistance, HOMA-IR, steatosis, metabolic syndrome, fibrosis

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder worldwide, strongly associated with obesity, insulin resistance, and metabolic syndrome. The disease ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. This study evaluates clinical, laboratory, and instrumental findings in patients with NAFLD and assesses metabolic risk factors associated with disease severity.

NINE muqovasi

Downloads

Published

2026-06-02

Issue

Vol. 3 No. 6 (2026): June 2026

Section

Articles

License

Copyright (c) 2026 The author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

NONALCOHOLIC FATTY LIVER DISEASE: CLINICAL FEATURES,DIAGNOSIS AND OUTCOMES. (2026). New Innovations in National Education, 3(6). https://doi.org/10.5281/zenodo.20511832

References

1. Younossi ZM et al. Global epidemiology of NAFLD. Hepatology. 2020.

2. Eslam M, Newsome PN. MAFLD concept and metabolic dysfunction. J Hepatol. 2020.

3. Loomba R, Adams LA. Advances in NAFLD diagnosis. Nat Rev Gastroenterol Hepatol. 2021.

4. Byrne CD, Targher G. NAFLD as multisystem disease. J Hepatol. 2018–2021.

5. Tilg H, Effenberger M. Insulin resistance in NAFLD. Hepatology. 2020.

6. Angulo P et al. Natural history of NAFLD. Gastroenterology. 2019.

7. European Association for the Study of the Liver (EASL) guidelines. 2021.